PrimeRFP SCOUT · Federal Contract Recompete Brief

FA301622F0063Fentanyl norfentanyl immunoassy reagent KITS — Alere San Diego, Inc

Alere San Diego, Inc holds $42.8M across 9,132 federal awards, concentrated at Department of Defense (DOD). PoP ended Sep 27, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fa3016 502 Cons Cl

Awarding office

Alere San Diego, Inc

Recipient

Sep 27, 2022

PoP end

$404K

Obligated

$651K

Potential

325413

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Alere San Diego, Inc — $90

Contract facts

Federal

Contract numberFA301622F0063

Also listed asFA3016-22-F-0063

Also listed asN6264520D5004-FA301622F0063

AgencyFa3016 502 Cons Cl

Awarding officeFa3016 502 Cons Cl

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAlere San Diego, Inc

CAGE6W6P3

UEITWMQTHHN6HM5

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264520D5004

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startNov 5, 2021

PoP end (current)Sep 27, 2022

Obligated$404K

Current value$651K

Potential value$651K

FENTANYL /NORFENTANYL IMMUNOASSY REAGENT KITS is a federal award for Fa3016 502 Cons Cl held by Alere San Diego, Inc. Estimated value $651K ($404K obligated). Current period of performance ends Sep 27, 2022. Place of performance: SAN DIEGO CA.

FENTANYL /NORFENTANYL IMMUNOASSY REAGENT KITS

Recompete timing

Public

● Past PoP end (1424 days ago)

Current PoP ended Sep 27, 2022 (1424 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Alere San Diego, Inc — $42.8M obligated across 9,132 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($42.8M) · all agencies · Top 3 shown (3%); remaining ~97% is other agencies.

Department of Defense (DOD)$770K · 2%

Court Services and Offender Supervision Agency (CSOSA)$625K · 1%

Department of Transportation (DOT)$51K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract FA301622F0063?

FA301622F0063 (Fentanyl norfentanyl immunoassy reagent KITS) is a Fa3016 502 Cons Cl award with a potential value of $651K, currently held by Alere San Diego, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is FA3016-22-F-0063?

FA3016-22-F-0063 is the dashed form of PIID FA301622F0063 (Fentanyl norfentanyl immunoassy reagent KITS), held by Alere San Diego, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded FA301622F0063?

Fa3016 502 Cons Cl awarded FA301622F0063 to Alere San Diego, Inc (potential $651K).

Who is the incumbent on FA301622F0063?

Alere San Diego, Inc is the incumbent with $42.8M across 9132 related awards in SCOUT’s public footprint. The current period of performance ends Sep 27, 2022.

When does Alere San Diego, Inc’s FA301622F0063 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 27, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Jun 24, 2022